Xenon Pharmaceuticals Inc... (XENE)

AI Score

Unlock

29.42

-1.29 (-4.20%)

At close: Apr 04, 2025, 3:59 PM

29.28

-0.47%

After-hours: Apr 04, 2025, 05:47 PM EDT

Xenon Pharmaceuticals Balance Sheet Statement

Chart Mode

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
Cash & Equivalents	142.71M	148.64M	57.24M	175.69M	45.01M	24.75M	67.75M	20.49M	17.09M	58.65M	72.03M	37.95M	60.16M
Short-Term Investments	484.19M	489.44M	534.85M	376.09M	131.99M	116.6M	51.55M	23.18M	47.05M	n/a	12.02M	11.33M	n/a
Long-Term Investments	n/a	292.79M	128.68M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	7.4M	7.75M	n/a	n/a	n/a	-105K	230K	408K	1.09M	n/a	2.74M	-2.6M
Receivables	1.47M	874K	986K	2.77M	1.82M	813K	151K	438K	200K	315K	215K	440K	392K
Inventory	n/a	n/a	-986K	-2.77M	-1.82M	n/a	n/a	1.00	1.00	-315K	1.00	1.00	n/a
Other Current Assets	6.89M	6.01M	7.22M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	149K
Total Current Assets	635.26M	644.96M	600.3M	559.02M	181.78M	144.87M	121.44M	44.82M	65.67M	60.87M	84.94M	49.87M	60.7M
Property-Plant & Equipment	18.22M	18.85M	16.91M	12.52M	6.88M	2.59M	991K	1.07M	1.4M	1.99M	2.48M	1.88M	2.6M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	27.88M	319.84M	153.85M	12.99M	7.4M	2.83M	991K	1.3M	1.81M	3.08M	2.48M	4.62M	2.6M
Total Assets	798.14M	964.8M	754.15M	572.01M	189.19M	147.7M	122.43M	46.12M	67.49M	63.95M	87.42M	54.49M	63.3M
Account Payables	5.07M	8.6M	8.49M	3.82M	3.04M	2.47M	665K	1.25M	1.46M	1.09M	553K	391K	821K
Deferred Revenue	n/a	n/a	n/a	9.29M	3.64M	29.74M	-15.01M	n/a	n/a	157K	11.62M	15.92M	17.02M
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	4.65M	n/a	700K	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	9.93M	347K	7.9M	3.95M	4.97M	3.45M	1.73M	44K	59K	775K	1.03M	1.37M	244K
Total Current Liabilities	35.59M	27.27M	22.7M	14.32M	14.78M	43.38M	4.12M	4.08M	3.52M	2.78M	14.29M	18.2M	19.2M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	10.89M	15.01M	6.1M	n/a	n/a	n/a	n/a	1.67M
Other Long-Term Liabilities	26.57M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	133K	196K	282K	184K
Total Long-Term Liabilities	34.22M	9.6M	9.95M	7.65M	3.05M	12.34M	15.01M	6.1M	70K	133K	353K	12.17M	31.49M
Total Liabilities	43.24M	36.88M	32.65M	21.97M	17.83M	55.72M	19.13M	10.19M	3.59M	2.92M	14.64M	30.37M	50.68M
Total Debt	9.02M	10.9M	10.44M	8.26M	3.31M	16.45M	15.01M	6.8M	n/a	n/a	n/a	n/a	1.67M
Common Stock	1.46B	1.44B	1.07B	783.17M	397.75M	294.24M	265.92M	173.84M	173.25M	148.63M	147.16M	6.15M	6.01M
Retained Earnings	-899.47M	-665.14M	-482.75M	-357.37M	-278.49M	-249.66M	-207.88M	-173.39M	-142.68M	-119.69M	-103.73M	-116.75M	-128.78M
Comprehensive Income	-1.61M	-77K	-3M	-990K	-990K	-990K	-990K	-990K	-990K	-990K	-990K	2.51M	3.75M
Shareholders Equity	754.9M	927.92M	721.5M	550.03M	171.35M	91.98M	103.3M	35.93M	63.9M	61.03M	72.78M	24.12M	12.62M
Total Investments	484.19M	782.23M	663.53M	376.09M	131.99M	116.6M	51.55M	23.18M	47.05M	n/a	12.02M	11.33M	n/a